preloader icon

are you interested in becoming a

Client

Choose our financial services for a tailored investment experience. Our advanced technology and dedicated support staff prioritize your financial goals, offering personalized care to ensure your success. Invest with us, where your needs come first.

Know More
Trader

Elevate your strategy with us. Benefit from minimal costs, the lowest interest rates, and cutting-edge technology. Experience near-zero downtime and a supportive atmosphere. Join our financial services firm and trade in an environment that values your success.

Know More
Business Partner

Join our expansive network of partners across India and experience unparalleled support for all your client needs. We understand the importance of clear communication and ensure seamless, automatic, and periodic payments of incentives and commissions. Partner with us, where your growth and client satisfaction are our top priorities.

Know More

What We offer

AGS elevates your trading experience by merging cutting-edge technology with direct access to India's esteemed exchanges. Our innovative tools harness data analytics to transcend emotional investing, enabling informed decisions. Invest smart, trade with confidence, and let technology chart your path to financial success

Currency Trading
Currency Trading
Equity
Equity
Derivatives Trading
Derivatives Trading
Commodities
Commodities
Depository Services
Depository Services
Sovereign Gold Bond
Sovereign Gold Bond
Exchange Traded Funds
Exchange Traded Funds
Wealth Management
Wealth Management

Financials Updates



SIP Calculator

₹

Total value of your investment:

  • Invested Amount
  • Est. Returns
  • Total Amount

    ₹ 0
  • Invested Amount

    ₹ 0
  • Estimated Returns

    ₹ 0

Financial  News

16-Nov-2026
Anuh Pharma Shares Gain 1.66% After Inaugurating New Manufacturing Facility in Maharashtra

Anuh Pharma is currently trading at RS 83.89, up by RS 1.37 points or 1.66% from its previous closing of RS 82.52 on the BSE.

The scrip opened at RS 82.65 and touched an intraday high and low of RS 84.00 and RS 82.45, respectively. So far, around 4,864 shares have been traded on the counter.

The BSE Group 'B' stock, with a face value of RS 5, recorded a 52-week high of RS 99.50 on September 9, 2026, and a 52-week low of RS 66.72 on March 30, 2026.

The stock's last one-week high and low stood at RS 84.48 and RS 80.98, respectively. The company's current market capitalisation stands at RS 831.86 crore.

The promoters hold a 71.80% stake in the company, while institutional and non-institutional investors hold 0.11% and 28.09%, respectively.

Anuh Pharma has inaugurated its new manufacturing facility located at Tarapur, Boisar, in Palghar district of Maharashtra. The new plant is expected to become fully operational by December 2026.

Upon commencement of operations, the facility will add 525 metric tonnes per annum (MT/Annum) to the company's existing manufacturing capacity. Currently, Anuh Pharma has an installed production capacity of approximately 2,400 MT per annum, which is expected to increase to around 2,925 MT per annum following the expansion.

Furthermore, the F-10/1 manufacturing facility includes the installation of an additional 56 KL of reactor capacity, further strengthening the company's manufacturing infrastructure and enabling it to cater to growing market demand.

Established in 1960, Anuh Pharma is one of India's largest manufacturers of Macrolides and Anti-TB products.

16-Nov-2026
eClerx Services Gains 1.69% After Subsidiary Signs Agreement to Acquire RegEdge LLC for Up to $12 Million

eClerx Services is currently trading at RS 1,576.05, up by RS 26.15 points or 1.69% from its previous closing of RS 1,549.90 on the BSE.

The scrip opened at RS 1,549.00 and touched an intraday high and low of RS 1,588.00 and RS 1,525.25, respectively. So far, around 4,800 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 10, recorded a 52-week high of RS 2,492.98 on January 6, 2026, and a 52-week low of RS 1,319.05 on June 30, 2026.

The stock's last one-week high and low stood at RS 1,630.00 and RS 1,517.80, respectively. The company's current market capitalisation stands at RS 14,602.31 crore.

The promoters hold a 54.52% stake in the company, while institutional and non-institutional investors hold 34.25% and 11.23%, respectively.

eClerx Services, through its wholly owned subsidiary, eClerx LLC, has signed a Membership Interest Purchase Agreement to acquire RegEdge LLC, a limited liability company incorporated under the laws of Delaware, USA.

Under the terms of the purchase agreement, eClerx LLC will pay an aggregate consideration of up to $12 million for the acquisition. The transaction is expected to be completed within two weeks, subject to the fulfilment of closing conditions.

The acquisition aims to strengthen the company's service offerings in the financial services sector, particularly in trade and transaction reporting, surveillance, financial crime compliance, and regulatory change management.

eClerx Services provides business process management, automation, and analytics services to several enterprises, including leading global companies across financial services, communications, retail, fashion, media and entertainment, manufacturing, travel and leisure, and technology sectors.

16-Nov-2026
Innovision Secures RS 10.99 Crore Work Order from NHAI; Shares Gain 1.43%

Innovision is currently trading at RS 269.85, up by RS 3.80 or 1.43% from its previous closing of RS 266.05 on the BSE.

The scrip opened at RS 274.00 and touched an intraday high and low of RS 274.00 and RS 267.55, respectively. So far, 85 shares have been traded on the counter.

The BSE Group 'B' stock, with a face value of RS 10, recorded a 52-week high of RS 468.60 on March 23, 2026, and a 52-week low of RS 179.20 on October 27, 2026.

The stock's last one-week high and low stood at RS 287.70 and RS 263.65, respectively. The company's current market capitalisation stands at RS 642.60 crore.

The promoters hold a 74.17% stake in the company, while institutional and non-institutional investors hold 6.08% and 19.75%, respectively.

Innovision has received a Letter of Award (LoA)/work order worth RS 10.99 crore from the National Highways Authority of India (NHAI).

The work order is for the engagement of user fee collection services at Patnipartapur Toll Plaza on NH-709A, located on the Meerut to Haryana/UP Border route in Uttar Pradesh. The contract also includes the upkeep and maintenance of adjacent toilet blocks, along with the replenishment of consumable items.

The order has been awarded for a period of 90 days.

Innovision is engaged in providing manpower services, toll plaza management and skill development training to clients across India.

16-Nov-2026
Glenmark Pharmaceuticals Shares Gain 0.76% After US Subsidiary Launches Generic Cancer Drug Axitinib

Glenmark Pharmaceuticals is currently trading at RS 2,663.00, up by RS 20.00 points or 0.76% from its previous closing of RS 2,643.00 on the BSE.

The scrip opened at RS 2,640.50 and touched an intraday high and low of RS 2,685.00 and RS 2,635.00, respectively. So far, around 5,167 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 1, recorded a 52-week high of RS 2,713.75 on November 9, 2026, and a 52-week low of RS 1,811.00 on November 17, 2025.

The stock's last one-week high and low stood at RS 2,713.75 and RS 2,571.20, respectively. The company's current market capitalisation stands at RS 75,777.32 crore.

The promoters hold a 46.65% stake in the company, while institutional and non-institutional investors hold 39.19% and 14.17%, respectively.

Glenmark Pharmaceuticals' wholly owned US subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Axitinib Tablets in 1 mg and 5 mg strengths. The product is an Authorized Generic version of INLYTA (axitinib) tablets.

According to IQVIA sales data for the 12-month period ending September 2026, annual US sales of INLYTA Tablets stood at approximately $538.4 million.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with a presence across Generics, Specialty and OTC businesses, operating in more than 50 countries.

16-Nov-2026
Brainbees Solutions Gains 0.62% as Globalbees Acquires 100% Stake in Dynamic IT Solution

Brainbees Solutions is currently trading at RS 161.60, up by RS 1.00 or 0.62% from its previous closing of RS 160.40 on the BSE.

The scrip opened at RS 166.00 and touched an intraday high and low of RS 168.95 and RS 160.85, respectively. So far, around 1,971 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 2, recorded a 52-week high of RS 348.50 on November 17, 2025, and a 52-week low of RS 156.80 on October 30, 2026.

The stock's last one-week high and low stood at RS 168.95 and RS 158.35, respectively. The company's current market capitalisation stands at RS 8,374.33 crore.

Institutional and non-institutional investors hold 27.62% and 72.38% stakes in the company, respectively.

Brainbees Solutions' material subsidiary, Globalbees Brands, has acquired an additional stake in Dynamic IT Solution, a step-down subsidiary of the company.

Globalbees has acquired an additional 10.09% shareholding in Dynamic IT from its existing shareholders. Following this transaction, Globalbees' shareholding in Dynamic IT has increased from 89.91% to 100%, including shares held by its nominee. The total cost of acquisition was RS 1.02 crore.

Brainbees Solutions operates the online platform 'FirstCry', which offers a wide range of products for mothers, babies and children.

12-Nov-2026
MRF Shares Gain 0.84% Despite 27.84% Decline in Q2 Net Profit

MRF is currently trading at RS 126,120.00, up by RS 1,049.15 points or 0.84% from its previous closing of RS 125,070.85 on the BSE.

The scrip opened at RS 125,084.20 and touched an intraday high and low of RS 126,520.00 and RS 123,796.45, respectively. So far, 561 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 10, recorded a 52-week high of RS 159,799.95 on November 10, 2025, and a 52-week low of RS 115,333.30 on October 29, 2026.

The stock's last one-week high and low stood at RS 128,000.00 and RS 117,000.00, respectively. The company's current market capitalisation stands at RS 53,520.81 crore.

The promoters hold a 27.61% stake in the company, while institutional and non-institutional investors hold 29.80% and 42.58%, respectively.

MRF has reported a 27.84% year-on-year decline in its net profit at RS 369.15 crore for the second quarter ended September 30, 2026 (Q2FY27), compared to RS 511.59 crore in the corresponding quarter of the previous year.

However, the company's total income increased by 17.61% to RS 8,651.63 crore in Q2FY27, against RS 7,356.38 crore reported in the corresponding quarter of the previous financial year.

On a consolidated basis, MRF reported a 26.63% year-on-year decline in net profit at RS 386.99 crore for the quarter ended September 30, 2026, compared to RS 527.43 crore in the same quarter last year.

Meanwhile, consolidated total income increased by 17.39% to RS 8,791.58 crore in Q2FY27, compared to RS 7,489.00 crore in the corresponding quarter of the previous year.

12-Nov-2026
Innovision Shares Gain 4.92% After Securing RS 12.16 Crore NHAI Work Order

Innovision is currently trading at RS 287.70, up by RS 13.50 points or 4.92% from its previous closing of RS 274.20 on the BSE.

The scrip opened at RS 287.70 and touched an intraday high and low of RS 287.70 and RS 287.70, respectively. So far, 50 shares have been traded on the counter.

The BSE Group 'B' stock, with a face value of RS 10, recorded a 52-week high of RS 468.60 on March 23, 2026, and a 52-week low of RS 179.20 on October 27, 2026.

The stock's last one-week high and low stood at RS 287.70 and RS 252.00, respectively. The company's current market capitalisation stands at RS 685.11 crore.

The promoters hold a 74.17% stake in the company, while institutional and non-institutional investors hold 6.08% and 19.75%, respectively.

Innovision has received a Letter of Award (LoA)/work order worth RS 12.16 crore from the National Highways Authority of India (NHAI).

The work order involves the engagement of a user fee collection agency through competitive bidding via e-tender for the Shamli to Muzaffarnagar section of National Highway 709AD in Uttar Pradesh. The scope of work also includes the upkeep and maintenance of adjacent toilet blocks, along with replenishment of consumable items. The order will be executed over a period of 90 days.

Innovision is engaged in providing manpower services, toll plaza management and skill development training to clients across India.

12-Nov-2026
HFCL Shares Gain 2.41% After Securing Export Orders Worth RS 834.36 Crore

HFCL is currently trading at RS 216.50, up by RS 5.10 points or 2.41% from its previous closing of RS 211.40 on the BSE.

The scrip opened at RS 215.60 and touched an intraday high and low of RS 217.90 and RS 212.65, respectively. So far, 28,206 shares have been traded on the counter.

The BSE Group 'T' stock, with a face value of RS 1, recorded a 52-week high of RS 282.10 on October 21, 2026, and a 52-week low of RS 59.83 on January 23, 2026.

The stock's last one-week high and low stood at RS 220.00 and RS 202.00, respectively. The company's current market capitalisation stands at RS 32,356.94 crore.

The promoters hold a 28.29% stake in the company, while institutional and non-institutional investors hold 26.09% and 45.61%, respectively.

HFCL has secured export orders worth approximately RS 834.36 crore (equivalent to around $88.94 million) through its overseas wholly owned subsidiary from a renowned international customer for the supply of optical fiber cables. The orders are scheduled to be executed by June 2027.

These orders reaffirm the confidence placed by customers in HFCL's manufacturing capabilities, technological excellence and product quality.

HFCL is a leading technology enterprise engaged in high-end telecommunications and defence equipment, optical fiber and optical fiber cables. The company also develops digital networks for telecom operators, enterprises and defence forces.

12-Nov-2026
Tata Power Shares Gain 0.50%; Consolidated Q2 Net Profit Rises 48.58% to RS 1,366.11 Crore

Tata Power Company is currently trading at RS 362.75, up by RS 1.80 or 0.50% from its previous closing of RS 360.95 on the BSE.

The scrip opened at RS 362.75 and touched an intraday high and low of RS 367.60 and RS 358.40, respectively. So far, 5,04,759 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 1, recorded a 52-week high of RS 464.80 on April 28, 2026, and a 52-week low of RS 333.30 on October 26, 2026.

The stock's last one-week high and low stood at RS 370.05 and RS 348.05, respectively. The company's current market capitalisation stands at RS 1,16,182.55 crore.

The promoters hold a 46.86% stake in the company, while institutional and non-institutional investors hold 28.62% and 24.52%, respectively.

Tata Power Company has reported a 63.29% year-on-year jump in its standalone net profit at RS 703.95 crore for the quarter ended September 30, 2026 (Q2FY27), compared to RS 431.10 crore in the corresponding quarter of the previous year.

The company's standalone total income more than doubled to RS 7,113.41 crore in Q2FY27, compared to RS 3,395.27 crore in the corresponding quarter of the previous year.

On a consolidated basis, the company reported a 48.58% year-on-year rise in net profit at RS 1,366.11 crore for Q2FY27, compared to RS 919.44 crore in the same quarter of the previous year.

Consolidated total income increased by 24.39% to RS 19,964.30 crore in Q2FY27, against RS 16,050.32 crore reported in the corresponding quarter of the previous financial year.

12-Nov-2026
Adani Enterprises Gains 0.33%; Subsidiary Incorporates Adani Rovuma Chemicals in UAE

Adani Enterprises is currently trading at RS 2,743.00, up by RS 9.00 points or 0.33% from its previous closing of RS 2,734.00 on the BSE.

The scrip opened at RS 2,722.80 and touched an intraday high and low of RS 2,757.95 and RS 2,720.00, respectively. So far, 15,639 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 1, recorded a 52-week high of RS 3,245.00 on July 6, 2026, and a 52-week low of RS 1,753.45 on March 30, 2026.

The stock's last one-week high and low stood at RS 2,774.00 and RS 2,680.00, respectively. The company's current market capitalisation stands at RS 3,71,326.11 crore.

The promoters hold a 71.97% stake in the company, while institutional and non-institutional investors hold 21.28% and 6.74%, respectively.

Adani Enterprises' wholly owned subsidiary, Adani Global, has incorporated another wholly owned subsidiary named Adani Rovuma Chemicals (ARCL) in the United Arab Emirates on November 10, 2026. The certificate of registration for the new entity was also received on November 10, 2026.

Adani Rovuma Chemicals has been incorporated to undertake the activities of a holding company for gas-to-chemical projects.

Adani Enterprises (AEL), the flagship company of the Adani Group, operates in integrated resource management, mining services and other trading activities. The company also functions as an incubator, establishing new businesses across various sectors, including the new energy ecosystem, data centres, airports, roads, copper, digital space and other emerging areas.

Trading Partner

My Algomate My Algomate
Trading View Trading View
Quantower Quantower
Convex Convex
MARKET  MAYA MARKET MAYA

Fraud Alert!

  • Beware of fraudulent individuals and agencies may be falsely claiming to be associated with AG Shares and Securities Ltd by creating fake websites, apps, and running scams on WhatsApp, Telegram and other social media platforms.
  • AG Shares and Securities Ltd has no connection with these entities and has the following official communicating channels only.
!Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.